MBMarc D. Basson

Marc D. Basson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc D. Basson has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher P. Gayer

    Departments of 1Surgery, 2Anesthesiology, and 3Anatomy and Cell Biology, John D. Dingell VA Medical Center and Wayne State University, Detroit, Michigan; 4Department of Immunology and Microbiology, University of Michigan, Ann Arbor, Michigan; 5Oncology Research Institute, Greenville Hospital System, Greenville, South Carolina; and 6Department of Biological Sciences, Clemson University, Clemson, South Carolina

    2 shared publications
  • David H. Craig

    ‡Departments of Surgery, John D. Dingell Veterans Affairs Medical Center and §Detroit Medical Center, Detroit, Michigan 48301 and the ¶Department of Anatomy and Cell Biology, Wayne State University, Detroit, Michigan 48201

    2 shared publications
  • Bixi Zeng

    Department of Surgery, Michigan State University College of Human Medicine, 1200 E Michigan Ave, Lansing Charter Township, MI 48912, USA

    1 shared publication
  • Christina Downey

    Department of Surgery, Michigan State University College of Human Medicine, 1200 E Michigan Ave, Lansing Charter Township, MI 48912, USA

    1 shared publication
  • Jetze J. Tepe

    Department of Pharmacology, Michigan State University, 1355 Bogue Street, B440 Life Sciences Building, East Lansing, MI 48824, USA

    1 shared publication
  • Jinhua Li

    Departments of 1Surgery, 2Anesthesiology, and 3Anatomy and Cell Biology, John D. Dingell VA Medical Center and Wayne State University, Detroit, Michigan; 4Department of Immunology and Microbiology, University of Michigan, Ann Arbor, Michigan; 5Oncology Research Institute, Greenville Hospital System, Greenville, South Carolina; and 6Department of Biological Sciences, Clemson University, Clemson, South Carolina

    1 shared publication

Latest Publications

  • Open Access

    Schlafen 3 Mediates the Differentiating Effects of Cdx2 in Rat IEC-Cdx2L1 Enterocytes.

    by Mary F. Walsh, Rebecca Hermann, Jun Hee Lee, Lakshmishankar Chaturvedi, Marc D. Basson

    Aim: Mature, differentiated enterocytes are essential for normal gut function and critical to recovery from pathological conditions. Little is known about the factors that regulate intestinal epithelial cell differentiation in the adult intestine. The transcription factor, Cdx2, involved in enterocytic differentiation, remains expressed in the adult. Since we have implicated Slfn3 in differentiation in vivo and in vitro, we examined whether it also mediated differentiation in the IEC-Cdx2-L1 cell model of differentiation. Materials and Methods: IEC-Cdx2-L1 cells, permanently transfected with Cdx2 under the control of isopropyl-β-D-thiogalactoside (IPTG), were stimulated to differentiate by 16-day exposure to IPTG. Transcript levels of Cdx2, Slfn 3, and villin were determined by quantitative reverse transcriptase-polymerase chain reaction of mRNA isolated from IPTG-treated and control cells. Slfn3 expression was lowered with specific siRNA to investigate the role of Slfn3 in Cdx2-driven villin expression in IPTG-differentiated cells. Results: Slfn3 and villin expression were significantly greater in IPTG-treated cells. Slfn3 siRNA lowered Slfn3 expression and abolished the IPTG-induced rise in villin expression (p < .05 by ANOVA); Cdx2 expression was unaffected by Slfn3 siRNA. Discussion: The data indicate that the presence of Slfn3 is required for Cdx2 to induce villin expression, and thus differentiation. However, Slfn3 must also promote differentiation of Cdx2 independently since IEC-6 cells that do not normally express Cdx2 can be differentiated by a variety of Slfn3-dependent mechanisms.


  • Open Access

    Increased extracellular pressure stimulates tumor proliferation by a mechanosensitive calcium channel and PKC‐β

    by Marc D. Basson, Bixi Zeng, Christina Downey, Madhu P. Sirivelu, Jetze J. Tepe

    Large tumors exhibit high interstitial pressure heightened by growth against the constraining stroma. Such pressures could stimulate tumor proliferation via a mechanosensitive ion channel. We studied the effects of 0–80 mmHg increased extracellular pressure for 24 h on proliferation of SW620, Caco‐2, and CT‐26 colon; MCF‐7 breast; and MLL and PC3 prostate cancer cells, and delineated its mechanism in SW620 cells with specific inhibitors and siRNA. Finally, we compared NF‐kB, phospho‐IkB and cyclin D1 immunoreactivity in the high pressure centers and low pressure peripheries of human tumors. Pressure‐stimulated proliferation in all cells. Pressure‐driven SW620 proliferation required calcium influx via the T‐type Ca2+ channel Cav3.3, which stimulated PKC‐β to invoke the IKK‐IkB–NF–kB pathway to increase proliferation and S‐phase fraction. The mitotic index and immunoreactivity of NF‐kB, phospho‐IkB, and cyclin D1 in the center of 28 large human colon, lung, and head and neck tumors exceeded that in tumor peripheries. Extracellular pressure increases [Ca2+]i via Cav3.3, driving a PKC‐β‐ IKK‐ IkB–NF–kB pathway that stimulates cancer cell proliferation. Rapid proliferation in large stiff tumors may increase intratumoral pressure, activating this pathway to stimulate further proliferation in a feedback cycle that potentiates tumor growth. Targeting this pathway may inhibit proliferation in large unresectable tumors.


  • Increased extracellular pressure enhances cancer cell integrin-binding affinity through phosphorylation of β1-integrin at threonine 788/789

    by David H. Craig, Christopher P. Gayer, Keri L. Schaubert, Yanzhang Wei, Jinhua Li, Yasmina Laouar, Marc D. Basson

    Increased extracellular pressure stimulates β1-integrin-dependent cancer cell adhesion. We asked whether pressure-induced adhesion is mediated by changes in β1-integrin binding affinity or avidity and whether these changes are phosphorylation dependent. We evaluated integrin affinity and clustering in human SW620 colon cancer cells by measuring differences in binding between soluble Arg-Gly-Asp (RGD)-Fc ligands and RGD-Fc-F(ab′)2 multimeric complexes under ambient and 15-mmHg increased pressures. Phosphorylation of β1-integrin S785 and T788/9 residues in SW620 and primary malignant colonocytes was assessed in parallel. We further used GD25-β1-integrin-null murine fibroblasts stably transfected with either wild-type β1A-integrin, S785A, TT788/9AA, or T788D mutants to investigate the role of β1-integrin site-specific phosphorylation. SW620 binding of RGD-Fc-F(ab′)2 multimeric complexes, but not soluble RGD-Fc ligands, was sensitive to integrin clustering. RGD-Fc ligand binding was significantly increased under elevated pressure, suggesting that pressure modulates β1-integrin affinity. Pressure stimulated both β1-integrin S785 and T788/9 phosphorylation. GD25-β1A-integrin wild-type and S785A cells displayed an increase in adhesion to fibronectin under elevated pressure, an effect absent in β1-integrin-null and TT788/9AA cells. T788D substitution significantly elevated basal cell adhesion but displayed no further increase under pressure. These results suggest pressure-induced cell adhesion is mediated by β1-integrin T788/9 phosphorylation-dependent changes in integrin binding affinity.


  • Open Access

    Strain-induced Proliferation Requires the Phosphatidylinositol 3-Kinase/AKT/Glycogen Synthase Kinase Pathway

    by Christopher P. Gayer, Lakshmi S. Chaturvedi, Shouye Wang, David H. Craig, Thomas Flanigan, Marc D. Basson